Corporate highlights

$
287
M
total raised
$
1.1
B
total partnership value*
2 IND
S
planned by 2025

Scientific highlights

> TB
proprietary data generated
> M
cells imaged
> K
compound chemical library
*excluding royalties

Corporate documents

Video

Condensate-modifying drugs: a revolution in drug discovery
Learn how Dewpoint leverages condensate biology to expand the druggable target space to address diseases of high unmet need.
A Paradigm Shift in Cell Biology
Our founders and advisors explain how condensates drive cell function

Current investors

Key links

To know more about the science of condensates:

Contact us

Contact Investor Relations directly by email: ir@dewpointx.com

Subscribe to receive Dewpoint information:

Follow us

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
USA
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science